Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Abstract Background Fibroblast growth factor-23 (FGF23) has been associated to left ventricular (LV) hypertrophy and heart failure (HF) severity. We aimed to investigate the clinical correlates and prognostic value of intact FGF23 (iFGF23) in HF patients. Methods Patients with stable HF and left ven...
Main Authors: | Giuseppe Vergaro, Annamaria Del Franco, Alberto Aimo, Francesco Gentile, Vincenzo Castiglione, Federica Saponaro, Silvia Masotti, Concetta Prontera, Niccolò Fusari, Michele Emdin, Claudio Passino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03441-2 |
Similar Items
-
Serum intact fibroblast growth factor 23 in healthy paediatric population
by: Stanczyk Malgorzata, et al.
Published: (2021-07-01) -
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
by: Vincenzo Castiglione, et al.
Published: (2023-06-01) -
Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study
by: Yoshiuchi Kazuhiro, et al.
Published: (2011-06-01) -
Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
by: S. Heleen Binnenmars, et al.
Published: (2022-08-01) -
High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis
by: Yu-Wei Fang, et al.
Published: (2023-04-01)